Battle Superbugs on Twitter
RT @PeggyFund: Please save the date for our 2021 virtual
FIGHT C. DIFF Gala, to be held on Monday, November
1st at 8 pm EST. More details i…
C Diff Treatment
Clinical stage program targeting Clostridioides (Clostridium) difficile Infection,
Clostridioides difficile Infection Clinical Practice Guidelines (ASCRS, 2021)
2021 guidelines from the American Society of Colon and Rectal Surgeons, published in Diseases of the Colon and Rectum (also see reference)
C DIFF FOUNDATION on Twitter
#Cdiff Spores and More Live Broadcast to Podcast https://t.co/tWTyXNxBdd Guest Host: Kevin Hersh Welcomed the new tool available....For #Patients #families and #caregivers https://t.co/QtVwFElCbV#microbiome #clinicaltrials #gastroenterology #Cdifficile #healthcare #CDI pic.twitter.com/xQJOCVYprd— C DIFF FOUNDATION (@cdiffFoundation) September 15, 2021
NICE, PHE publish new antimicrobial prescribing guideline on C. difficile infection - PharmaTimes
New recommendations outlined include advice for managing C. difficile infection in both community and hospital settings
Pharmacy Quiz: Test Your Knowledge on C. Difficile Infection - Pharmacy Times
Ten quiz questions to assess your knowledge on common symptoms and treatments for Clostridioides difficile.
Drug recall for a mistake that may cause ‘persistent diarrhea’ and ‘potentially death’ - Miami Herald
A budget impact analysis of bezlotoxumab versus standard of care antibiotics only in patients at high risk of CDI recurrence from a hospital management perspective in Germany
The study demonstrated administration of SoC + bezlotoxumab in patients at high risk of CDI recurrence is cost-saving from a hospital management perspective. Reduced length of stay in bezlotoxumab treated patients creates free spatial and personnel capacities for the treating hospital. Yet, a requir …
Azurity Recalls C Difficile Treatment Due to Diluent Mix-Up - MD Magazine
One lot of the vancomycin kits mistakenly contained a first omeprazole diluent.
Unrecognized Costs Associated With Clostridium Difficile Infection: What HCPs Often Miss - Pharmacy Times
From an economic perspective, C. difficile has a staggering financial impact on the US health care system, as well on the patients infected.
Living Without Fear of Clostridioides difficile | Everyday Health
Learn about the quality-of-life challenges experienced by patients and caregivers of people affected by C. diff, and become empowered to play an active role in treatment decisions.
Clinical Practice Guideline by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA): 2021 Focused Update Guidelines on Management of Clostridioides difficile Infection in Adults
This clinical practice guideline is a focused update on management of Clostridioides difficile infection (CDI) in adults specifically addressing the use of fidaxomicin and bezlotoxumab for the treatment of CDI. This guideline was developed by a multidisciplinary panel representing the Infectious Dis …
South African Society of Clinical Microbiology Clostridioides difficile infection diagnosis, management and infection prevention and control guideline
Clostridioides difficile infection (CDI) is a problem in both developed and developing countries and is a common hospital-acquired infection. This guideline provides evidence-based practical recommendations for South Africa and other developing countries. The scope of the guideline includes C …
Clostridium Difficile Infection Treatment Market North America to Witness Significant Growth, Owing To High Number of Substance Users in the Region – Eudaemonia - Eudaemonia
Clostridium difficile (C. diff) is a type of bacteria that can cause colitis, a serious inflammation
NICE, PHE publish new antimicrobial prescribing guideline on C. difficile infection - PharmaTimes
New recommendations outlined include advice for managing C. difficile infection in both community and hospital settings
Outcomes among inpatients with cirrhosis and Clostridioides difficile infection in the modern era: results from an analysis of the National Inpatient Sample
Mortality outcomes associated with CDI have improved over time. Patients with cirrhosis continue to exhibit greater LOS and hospital costs.
Bacteriocin Nisin Active Against C. Diff in Fecal Fermentation Model
Purified nisin is effective at killing Clostridioides difficile, a recent ex vivo study demonstrated, opening up the potential to use the bacteriocin as a treatment.
September is Sepsis Awareness Month. Many people who lose their life from a #Cdiff infection, die from sepsis. Peggy was one of those people. Knowing the signs of #sepsis while caring for someone with C. diff (or any infection), can help you save a life.
September is Sepsis Awareness Month. Many people who lose their life from a #Cdiff infection, die from sepsis. Peggy was one of those people. Knowing the signs of #sepsis while caring for someone with C. diff (or any infection), can help you save a life. #SepsisAwarenessMonth pic.twitter.com/DMKgMBxmkj— Peggy Lillis Fund (@PeggyFund) September 1, 2021
Ebselen Not Only Inhibits Clostridioides difficile Toxins but Displays Redox-Associated Cellular Killing
Ebselen, a reactive organoselenium compound, was shown to inhibit toxins TcdA and TcdB by covalently binding to their cysteine protease domains. It was suggested that ebselen lacked antimicrobial activity against Clostridioides difficile. However, this perception conflicts with C. difficile having e …
Some Differences Between ACG, IDSA/SHEA C. difficile Recommendations - Gastroenterology & Endoscopy News
Some Differences Between ACG, IDSA/SHEA C. difficile Recommendations - Gastroenterology & Endoscopy News
Add-on interventions for the prevention of recurrent Clostridioides Difficile infection: A systematic review and network meta-analysis
Add-on treatment with oligofructose, NTCD-M3 spores, rifaximin, RBX2660, and bezlotoxumab likely reduces the risk of CDI. Evidence on probiotics and SER-109 are uncertain, thus adequately powered trials are warranted.
Retrospective study of the efficacy and safety of metronidazole and vancomycin for Clostridioides difficile infection - ScienceDirect
According to the Japanese guidelines for the management of Clostridioides difficile infection (CDI), the first choice is metronidazole (MNZ) for non-s…
Guidance updated for managing C. difficile infection in adults - Medical Xpress
(HealthDay)—Use of fidaxomicin and bezlotoxumab is suggested in specific cases for management of Clostridioides difficile infection (CDI), according to a clinical practice guideline update issued by ...
Opportunities for Nanomedicine in Clostridioides difficile Infection
Clostridioides difficile, a spore-forming bacterium, is a nosocomial infectious pathogen which can be found in animals as well. Although various antibiotics and disinfectants were developed, C. difficile infection (CDI) remains a serious health problem. C. difficile spores have …
Teicoplanin Suppresses Vegetative Clostridioides difficile and Spore Outgrowth
In recent decades, the incidence of Clostridioides difficile infection (CDI) has remained high in both community and health-care settings. With the increasing rate of treatment failures and its ability to form spores, an alternative treatment for CDI has become a global priority. We used the …
Paradigm Shift in the Management of Clostridioides difficile Infections - Contagionlive.com
Microbiome Enrichment Bests Placebo for Recurrent C. difficile - Infectious Disease Special Edition
DIFICID should be a medicine available to everyone! #cdiff #cdifficile #Clostridiumdifficile #cdiffawareness you shouldn't have to die from pooping. Pooping is suppose to feel great. #guthealth #gut #dificid
DIFICID should be a medicine available to everyone! #cdiff #cdifficile #Clostridiumdifficile #cdiffawareness you shouldn't have to die from pooping. Pooping is suppose to feel great. #guthealth #gut #dificid— Lu (@GhettoLu) August 24, 2021
Pharmacological Management of Pediatric Clostridioides difficile Infection: Clarifying the Controversies
Clostridioides difficile infection (CDI) is a major public health concern for pediatric and adult patients. The management of pediatric CDI poses a challenge to healthcare providers due to lack of strong randomized controlled trials to guide pharmacological management. Additionally, recent updates t …